Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies

Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies; final; C. difficile infection, Fecal microbiota, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2W8bQx1